by akronbiotech

The Akron team recently attended the 4th Innate Killer Summit, held in in San Diego, California. The conference provided an excellent opportunity to participate in presentations and workshops covering cutting-edge research, recent clinical data, and commercial developments in the growing NK cell therapy market. More than 250 attendees collaborated and shared knowledge on ways we can make the future of NK cell immunotherapies safer and more effective.

Speakers from Dana-Farber Cancer Institute, Fate Therapeutics, the Karolinska Institutet, Poseida Therapeutics, the UCLA School of Dentistry and Medicine, Nohla Therapeutics and others presented recent discoveries and offered their insights into potential mechanisms and drivers for therapeutic use. A few key points are outlined below:

  • Dr. Rizwan Romee, the Director of the Haploidentical Donor Transplant Program at Dana Farber highlighted the use of memory-like NK cells and their main attributes. He also discussed the recent collaboration between Akron and Dana Farber involving cGMP cytokines as cell culture supplements and therapeutic agents.
  • Cyto-Sen CSO, Dr. Robert Igarashi, spoke about what defines ‘success’ for NK cell therapies, detailing historical evidence to address why NK cell dosage matters and what designates a ‘good’ NK cell.
  • Dr. Dean Lee, Professor of Pediatrics at Nationwide Children’s Hospital, focused on the importance of quality cryopreservation agents for NK cell therapy success and on the mechanisms of survival following cryopreservation. Though difficult to cryopreserve, Dr. Lee noted that NK cells which have been cryopreserved offered improved disease control and reduced viral re-activation.

Surrounded by academic researchers and industry leaders, Akron’s time in San Diego was well spent – gathering market insights to improve future developments. Our broad portfolio of cGMP products and services were showcased, especially our rHu cGMP IL-2, IL-15, IL-21, and various cryopreservation media.

The ability to engage with our peers and learn from their work is something we truly value at Akron. We look forward to attending the upcoming conferences on our schedule for 2019 and hope to see you there!



Related Post

Leave A Comment